FDA Drug · D-0839-2026

Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.

Class II · Ongoing

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

Advertisement
Advertisement
Affected lots / codes — check yours against thisLot #: 3225272, Exp. September 30, 2026
Recalling firm
Mylan Pharmaceuticals Inc, Morgantown, WV
Classification
Class II (temporary or reversible harm possible)
Status
Ongoing
Quantity
47,662 bottles
Distribution
Nationwide within the U.S
Recall initiated
August 17, 2026
Classified
September 11, 2026
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0839-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →